
Gender-affirming hormone treatment for 16 and 17-year-olds has been paused after an NHS review found evidence does not support its continued use.
The treatment, prescribing masculinising or feminising hormones, has been available on the NHS for 16 and 17-year-olds with a diagnosis of gender dysphoria who meet certain criteria, but new referrals have been paused from Monday.